Evidence map›Paper›PMID 25346505›Full record

ArticleAlcoholism, clinical and experimental research2014

Predictors of abstinence from heavy drinking during treatment in COMBINE and external validation in PREDICT.

Ralitza Gueorguieva, Ran Wu, Patrick G O'Connor, Constance Weisner, Lisa M Fucito, Sabine Hoffmann, Karl Mann, Stephanie S O'Malley

Abstract readComparative Study
In one paragraph

Article in Alcoholism, clinical and experimental research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. An analysis of moderators in the COMBINE study: Identifying subgroups of patients who benefit from acamprosate.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2015
    Trial
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ralitza GueorguievaYale University School of Public Health and School of Medicine, New Haven, CT 06520, USA.
Ran WuDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA.
Patrick G O'ConnorDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06519, USA.
Constance WeisnerKaiser Permanente Division of Research, Oakland, CA 94612, USA.
Lisa M FucitoDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA.
Sabine HoffmannDepartment of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159, Germany.
Karl Mann *Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159, Germany.
Stephanie S O'Malley *Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA.

Funding

Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
Improving Alcoholism TreatmentK05AA014715 · NIAAA · YALE UNIVERSITY · PI O'MALLEY, STEPHANIE S · 2004 to 2013
$2.1M
Trajectories of Drinking and Compliance in the COMBINE StudyR01AA017173 · NIAAA · YALE UNIVERSITY · PI GUEORGUIEVA, RALITZA, O'MALLEY, STEPHANIE S · 2008 to 2013
$981k
New Approaches to Smoking Cessation in Heavy DrinkersK23AA020000 · NIAAA · YALE UNIVERSITY · PI FUCITO, LISA M · 2011 to 2016
$755k
NCATS NIH HHS UL1 TR000142NIAAA NIH HHS K05 AA014715NIAAA NIH HHS K23 AA020000NIAAA NIH HHS R01 AA017173NIAAA NIH HHS R01AA017173
6 · The paper itself

Abstract

backgroundThe goal of the current study was to use tree-based methods (Zhang and Singer, 2010, Recursive Partitioning and Applications, 2nd ed. Springer, New York) to identify predictors of abstinence from heavy drinking in COMBINE (Anton et al. JAMA 2006; 295:2003), the largest study of pharmacotherapy for alcoholism in the United States to date, and to validate these results in PREDICT (Mann et al. Addict Biol 2012; 18:937), a parallel study conducted in Germany.

methodsWe compared a classification tree constructed according to purely statistical criteria to a tree constructed according to a combination of statistical criteria and clinical considerations for prediction of no heavy drinking during treatment in COMBINE. We considered over 100 baseline predictors. The tree approach was compared to logistic regression. The trees and a deterministic forest identified the most important predictors of no heavy drinking for direct testing in PREDICT.

resultsThe tree built using both clinical and statistical considerations consisted of 4 splits based on consecutive days of abstinence (CDA) prior to randomization, age, family history of alcoholism, and confidence to resist drinking in response to withdrawal and urges. The tree based on statistical considerations with 4 splits also split on CDA and age but also on gamma-glutamyl transferase level and drinking goal. Deterministic forest identified CDA, age, and drinking goal as the most important predictors. Backward elimination logistic regression among the top 18 predictors identified in the deterministic forest analyses identified only age and CDA as significant main effects. Longer CDA and goal of complete abstinence were associated with better outcomes in both data sets.

conclusionsThe most reliable predictors of abstinence from heavy drinking were CDA and drinking goal. Trees provide binary decision rules and straightforward graphical representations for identification of subgroups based on response and may be easier to implement in clinical settings.

Indexed as

Behavior TherapyDecision TreesAcamprosateAge FactorsAlcohol AbstinenceAlcohol DeterrentsAlcohol DrinkingCombined Modality TherapyControlled Clinical Trials as Topicgamma-GlutamyltransferaseGermanyGoalsHumansLogistic ModelsMiddle AgedNaltrexoneAcamprosateAlcohol Deterrentsgamma-GlutamyltransferaseNaltrexoneTaurineAlcohol DependenceClassification TreeClinical TrialDeterministic ForestLogistic Regression

Identifiers

PMID25346505
PMCPMC4397985

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.